BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone protein preparation has been accepted in Canada

22.10.2019 BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone protein preparation has been accepted in Canada Our company BBS-Bioactive Bone Substitutes Plc's patent application ” A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION CONTAINING POLYETHYLENE GLYCOL/GLYCEROL MATRIX AND CALCIUM SALT GRANULES ” has been accepted in Canada. The same European and Eurasian patent has been valid about three years. CEOIlkka Kangasniemi : ”This...

Oulu, 22/10/2019 (informazione.it - comunicati stampa - salute e benessere)

22.10.2019

BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone protein preparation has been accepted in Canada

Our company BBS-Bioactive Bone Substitutes Plc's patent application ” ” has been accepted in Canada. The same European and Eurasian patent has been valid about three years.

CEO :
”This is positive news for our company. This approval in Canada strengthens the patent protection of our ARTEBONE product and its unique component, bone protein extract, in the world.”

Ilkka Kangasniemi, CEO

tel. 040 7080307, e-mail: ilkka.kangasniemi@bbs-artebone.fi

Nasdaq Helsinki Oy

Nasdaq Stockholm AB

Main Media

www.bbs-artebone.fi

This is information that BBS-Bioactive Bone Substitutes Plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on 22nd October 2019 at 3:00 pm (UTC+2:00).

www.bbs-artebone.com

BBS' Certified Adviser at Nasdaq First North Growth Market Stockholm and Helsinki is Stockholm Certified Advisers AB, +46 70 5516 729, info@certifiedadviser.se .